Articles

Rosiglitazone and pioglitazone, both drugs commonly prescribed to treat type 2 diabetes double the risk of heart failure, a study of data on more than 78,000 patients suggests.

Lowering cholesterol with statins may slightly increase the risk of cancer, a study suggests more moderate doses.

For the first time, the ADA and the European Association for the Study of Diabetes (EASD) have spelled out a treatment regimen that recommends initial therapy with lifestyle modifications and metformin (a drug used for treating type 2 diabetes in adults and children) and the early addition of insulin therapy …

Obesity Is ‘Socially Contagious’ says a new report from Harvard. Need to associate only with skinny people if you want to be skinny?

Diet soft drinks are lower in calories, but are still associated with a greater risk of heart disease as are sugar-laden sodas, according to a new study.

The traditional Indian herbal Salacia oblonga, can be effective for diabetics to lower blood sugars by 23% and insulin responses by 29%, says a new study from the US that helps build the science behind the herb.

Patients often resist the advice of health care providers and thus neglect what is in their best interests. But research found that exploring a patient’s motivation for resistance, through a process call motivational interviewing, can greatly increase compliance.

Just a 1.3-g/day reduction in sodium, translates into a 5-mm-Hg smaller rise in systolic blood pressure. Between the ages of 25 and 55 years, this small reduction would translate into an estimated 150 000 lives saved.

Rosiglitazone Seen No Better than Other Drugs in Diabetic Control

In patients with peripheral arterial disease (PAD), guideline-based treatment with an antiplatelet agent is as effective with or without the addition of an anticoagulant. However, combination treatment is more hazardous than monotherapy with an antiplatelet, according to evidence from the Warfarin Antiplatelet Vascular Evaluation (WAVE) trial investigators